Targeting brain tumours with precision: advances in magnetic nanoparticle therapy
Open Access
- 9 December 2025
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 8 (2) , 458-478
Abstract
Schematic overview of magnetic nanoparticles in brain cancer therapy. MNPs enable magnetic hyperthermia, targeted drug delivery, and MRI imaging, while facing challenges in BBB penetration, toxicity, biodistribution, and long-term biocompatibility.Keywords
This publication has 81 references indexed in Scilit:
- Advanced nanotheranostic approaches for targeted glioblastoma treatment: a synergistic fusion of CRISPR-Cas gene editing, AI-driven tumor profiling, and BBB-modulationMedical Oncology, 2025
- Recent Advances in Nanoenzymes Based Therapies for Glioblastoma: Overcoming Barriers and Enhancing Targeted TreatmentAdvanced Science, 2025
- 3D In Vitro Glioma‐Neuron‐Astrocyte Biomimetic Composites Recapitulate Key Molecular Mechanisms Linked to Glioblastoma Multiforme PathophysiologyAdvanced Functional Materials, 2025
- Ligand-based active targeting strategies for cancer theranosticsNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Recent progress of magnetic nanoparticles in biomedical applications: A reviewNano Select, 2021
- Magnetic Nanoparticles in Cancer Therapy and DiagnosisAdvanced Healthcare Materials, 2020
- Metal Species–Encapsulated Mesoporous Silica Nanoparticles: Current Advancements and Latest BreakthroughsAdvanced Functional Materials, 2019
- Surface-functionalized magnetic nanoparticles in cancer-drug delivery and diagnosis2019
- Combined Magnetic Nanoparticle‐based MicroRNA and Hyperthermia Therapy to Enhance Apoptosis in Brain Cancer CellsSmall, 2014
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJournal of Neuro-Oncology, 2010